Funding for this research was provided by:
ARC discovery grant (DP130104407, DP130104407, DP130104407)
Received: 13 August 2019
Accepted: 16 January 2020
First Online: 6 February 2020
Ethics approval and consent to participate
: This study was approved by the Human Research Ethics Committee of the Universities of Sydney (no. 2014/017) with all participants providing informed consent online.
: Not applicable.
: Prof. Hunter reports consultant fees from Pfizer, Merck Serono, TLC Bio and Flexion, outside the submitted work. All the other authors declare that they have no competing interests.